GlaxoSmithKline Pharma, celebrating 100 years in India, is shifting to a specialty-focused model by entering the oncology ...

GlaxoSmithKline Pharma is shifting focus to specialty treatments and preventive healthcare, emphasizing adult vaccines and ...

GlaxoSmithKline (GSK) saw its shares jump more than 6% after the pharmaceutical giant announced a settlement of up to $2.2 ...

GlaxoSmithKline or GSK, is one of the most renowned pharma giants around the globe. In a recent development regarding the ...

HBA convenes global healthcare pharma, companies to advance women leadership in Indian healthcare: Our Bureau, Mumbai Monday, ...

Granules India's US subsidiary receives FDA approval for generic Bupropion Hydrochloride Extended-Release Tablets, expanding ...

This approval adds to Granules India's existing 67 ANDA approvals from the US FDA, strengthening its position in regulated ...

Nigeria’s manufacturing sector is under siege. The cruel combination of high energy costs, foreign exchange scarcity, rising ...

Granules India has received USFDA approval to market a generic medication for major depressive disorder, Bupropion ...

The medication is widely prescribed for the treatment of major depressive disorder and for the prevention of seasonal ...

GSK GSK-0.07%decrease; red down pointing triangle agreed to pay more than $2 billion to settle almost all remaining liability cases in the U.S. over allegations its discontinued heartburn medicine ...

GSK GSK-0.10%decrease; red down pointing triangle shares topped the Stoxx Europe 600 index on Thursday after the pharmaceutical company agreed to pay up to $2.2 billion to settle thousands of U.S ...